Download
1 / 5
60 likes | 73 Views
The United States Nuclear Medicine & Radio Pharmaceuticals industry is expected to grow at a higher CAGR in the upcoming period. Radiopharmaceuticals being radioactive compounds are administered to the patient and examined through specific imaging devices for therapeutic purposes. A radiopharmaceutical comprises radioisotope bond to an organic molecule and the organic molecule transports the radioisotope to respective organs, cells or tissues. From the commercial perspective, the nuclear medicine and radio pharmaceuticals are used for diagnosing Parkinson’s diseases and Alzheimer’s.<br>
E N D
United States Nuclear Medicine & Radio Pharmaceuticals Market Share & Emerging Trends Forecasts till 2025 Radiopharmaceuticals being radioactive compounds are administered to the patient and examined through specific imaging devices for therapeutic purposes. A radiopharmaceutical comprises radioisotope bond to an organic molecule and the organic molecule transports the radioisotope to respective organs, cells or tissues. The United States Nuclear Medicine & Radio Pharmaceuticals industry is expected to grow at a higher CAGR in the upcoming period. Radiopharmaceuticals being radioactive compounds are administered to the patient and examined through specific imaging devices for therapeutic purposes. A radiopharmaceutical comprises radioisotope bond to an organic molecule and the organic molecule transports the radioisotope to respective organs, cells or tissues. From the commercial perspective, the nuclear medicine and radio pharmaceuticals are used for diagnosing Parkinson’s diseases and Alzheimer’s. Browse Full Research Report @ https://www.millioninsights.com/industry-reports/united-states-nuclear-medicine-radio-pharmaceuticals-market
Driving factors to the United States nuclear medicines & radio pharmaceuticals industry includes rise in minimal invasive techniques entices more number of patients towards radio pharmaceuticals when compared to chemotherapy; also rising incidence of cardiac patients and inclination towards adoption of imaging techniques such as PET and SPECT contributes to the market growth in the United States. However, factors such as supply shortages, transportation difficulties and lack of trained personnel is likely to hinder the market growth. Segmentation by type for United States nuclear medicine &radio pharmaceuticals Industry includes therapeutic and diagnostic. By modality, the United States nuclear medicine & radio pharmaceuticals market includes PET, SPECT, beta-emitters, alpha-emitters and brachytherapy. Segmentation by application, the United States nuclear medicine & radio pharmaceuticals industry includes oncology, neurology, cardiology and thyroid. By procedures, the United States nuclear medicine & radio pharmaceuticals includes cardiovascular, oncology, central nervous system, skeletal, endocrine, gastrointestinal, pulmonary, genito-urinary, PET & PET-CT and therapeutic. Based on end-user segmentation, the United States nuclear medicine & radio pharmaceuticals market includes research institutes and hospitals and diagnostic centers. Geographical segmentation for United States nuclear medicine & radio pharmaceuticals industry spans The West, The Middle Atlantic, The Southwest and New England. The key players in the United States nuclear medicine & radio pharmaceuticals market include Bayer AG, Medtronic Inc, Lantheus Medical Imaging Inc, Cardinal Health and IBA Group. Request Sample Copy of this Market Research @ https://www.millioninsights.com/industry-reports/united-states-nuclear-medicine-radio-pharmaceuticals-market/request-sample Market Segment: Geographically, this report splits the United States market into seven regions: • The West • Southwest
• The Middle Atlantic • New England • The South • The Midwest with sales (volume), revenue (value), market share and growth rate of Nuclear Medicine & Radio Pharmaceuticals in these regions, from 2013 to 2025 (forecast). United States Nuclear Medicine & Radio Pharmaceuticals market competition by top manufacturers/players, with Nuclear Medicine & Radio Pharmaceuticals sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including • GE Healthcare • Philips Healthcare • Siemens Healthcare • Toshiba • Hitachi • Carestream • Esaote • Shimadzu • TriFoil Imaging • Biosensors International Group, Ltd See More Reports of this Category by Million Insights @ https://www.millioninsights.com/industry/pharmaceuticals
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into • Diagnostic Medicine: SPECT Radiopharmaceuticals, PET Radiopharmaceuticals • Therapeutic Medicine: Beta Emitters, Alpha Emitters, Brachytherapy Isotopes On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including • Diagnostic Applications: SPECT, PET. • Therapeutic Applications: Thyroid, Bone Metastasis, Lymphoma, Endocrine Tumors, Other Therapeutic Applications. Browse Full Research Report @ https://www.millioninsights.com/industry-reports/united-states-nuclear-medicine-radio-pharmaceuticals-market
Get in touch At Million Insights, we work with the aim to reach the highest levels of customer satisfaction. Our representatives strive to understand diverse client requirements and cater to the same with the most innovative and functional solutions. Contact Person: Ryan Manuel Research Support Specialist, USA Email: ryan@millioninsights.com Global Headquarters Asia Pacific Million Insights Million Insights Felton Office Plaza 6265 Highway 9 Felton, California 95018, United States Office No. 302, 3rd Floor, Manikchand Galleria, Model Colony, Shivaji Nagar, Pune, MH, 411016 India Phone: 1-408-610-2300 Email: sales@millioninsights.com Phone: 91-20-65300184 Email: sales@millioninsights.com Visit Our Blog: www.millioninsights.blogspot.com
